T29041 |
UCCF-853
|
625458-06-2
|
98%
|
|
UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
|
T10591L |
(R)-BPO-27
|
1415390-47-4
|
98%
|
|
(R)-BPO-27 is an orally active and potent ATP-competitive CFTR inhibitor (IC50: 4 nM) for the study of diarrhoea and polycystic kidney.
|
T10591 |
BPO-27 racemate
|
1314873-02-3
|
98%
|
|
BPO-27 racemate (BPO-27 (racemate)) is an effective CFTR inhibitor with IC50 of 8 nM.
|
T29114 |
VRT-532
|
38214-71-0
|
100%
|
|
VRT-532 (CFpot-532) is an effective modulator of CFTR and is commonly used in studies of cystic fibrosis (CF) caused by CFTR defects. Arylsulfatase B (ARSB), whi...
|
T2486 |
IOWH-032
|
1191252-49-9
|
98%
|
|
IOWH-032 (IOWH032) , a synthetic CFTR inhibitor, has been investigated for the treatment of cholera, diarrhea, and secretory diarrhea.
|
T2588 |
Ivacaftor
|
873054-44-5
|
98%
|
|
Ivacaftor (VX-770) (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively...
|
T60653 |
CFTR corrector 9
|
909861-78-5
|
98.24%
|
|
CFTR Corrector 9, a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, is employed in the research of cystic fibrosis (CF) and related CFTR-as...
|
T2451 |
GlyH-101
|
328541-79-3
|
98.31%
|
|
GlyH-101 is a cell-permeable glycinyl hydrazone compound that blocks CFTR with Ki of 1.4 uM.
|
T9499 |
Icenticaftor
|
1334546-77-8
|
98.39%
|
|
Icenticaftor (QBW251) is an orally active potentiator of CFTR channel.
|
T10776 |
CFTR corrector 4
|
1918142-34-3
|
98.43%
|
|
CFTR corrector 4 is a potent and orally available transmembrane conductance regulator (CFTR) for cystic fibrosis and is a potent (R,R) type active enantiomer. C...
|
T16681 |
Nesolicaftor
|
1953130-87-4
|
98.64%
|
|
Nesolicaftor (PTI-428) specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.
|
T77604 |
WAY-326766
|
853138-67-7
|
98.76%
|
|
WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF).
|
T2263 |
Tezacaftor
|
1152311-62-0
|
98.84%
|
|
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
|
T14935 |
Elexacaftor
|
2216712-66-0
|
98.87%
|
|
Elexacaftor (VX-445) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) and it also facilitates the processing and trafficking of CFTR ...
|
T26955 |
Cavosonstat
|
1371587-51-7
|
98.91%
|
|
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor that promotes cystic fibrosis transmembrane conductance regulator (CFTR...
|
T1874 |
PPQ-102
|
931706-15-9
|
99.17%
|
|
PPQ-102 (CFTR Inhibitor), an effective CFTR inhibitor, can completely inhibit CFTR chloride current (IC50: 90 nM).
|
T1634 |
Glibenclamide
|
10238-21-8
|
99.39%
|
|
Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
|
T1805 |
Ataluren
|
775304-57-9
|
99.45%
|
|
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Du...
|
T63806 |
CFTR corrector 8
|
1918142-35-4
|
99.58%
|
|
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). This compound is specifically designed for ut...
|
T3135 |
KM11060
|
774549-97-2
|
99.67%
|
|
KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma ...
|